Epoetin Alfa for HIV-Associated Neuropathy Trial
NCT00528593
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
lack of pharmaceutical support
Conditions
HIV Infections
Neuropathy
Interventions
DRUG:
epoetin alfa
Sponsor
Washington University School of Medicine
Collaborators
[object Object]
[object Object]
[object Object]